Management of depression induced by interferon hepatitis therapies
Hema Shah1, Snehal Kadia1, Radhika Bawa1
1Department of Psychiatry, University of Louisville School of Medicine, Louisville, Kentucky.
Objective:
Treatment with interferon therapy for hepatitis can induce depression and/or recurrence of affective illness, which could result in cessation of interferon treatment. This article reviews treatment for interferon-induced depression, including antidepressant drugs that may diminish associated symptoms.
Data Sources:
English-language literature with no date restrictions on the treatment of interferon-induced depression was reviewed via PubMed and MEDLINE using the key words hepatitis, interferon, hepatitis C, interferon-induced depression, pharmacotherapy of interferon-induced depression, and depression prevention. Fourteen of the most pertinent references are cited.
Data Extraction:
Escitalopram is the most prominently noted pharmaceutical prescribed for treating mood symptoms in hepatitis patients with interferon-induced depression. Other antidepressant medicines may have utility as well.
Results:
Antidepressant drugs can be efficacious in diminishing mood disorders during hepatitis therapies. It remains controversial as to whether antidepressant medications can provide prophylaxis against newly developing interferon-induced depressions in individuals with no past history of a mood disorder.
Conclusions:
Antidepressant medicines can be effective at improving mood in patients undergoing interferon treatment for hepatitis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antidepressant Drugs: MAOIs and Other Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Antidepressant Drugs: Overview
Depression: Overview
Myocarditis IV: Nursing Management


